NeoGenomics, Inc. ("NeoGenomics" or the "Company") (NASDAQ:NEO), a leading provider of oncology testing services, today announced the analytical validation of its PanTracer LBxtm assay, a ...

Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to significantly improve cancer outcomes for at-risk ...

Pierre Arsène, founder and CEO of Mursla Bio, said: “This designation is a powerful validation of both our scientific vision ...

Shorla’s new formulation is the only “ready-to-dilute multi-dose vial” of thiotepa for treating breast and ovarian cancer, ...

Mursla Bio, a Cambridge UK and Boston US leader in Extracellular Vesicle (EV) science, has received FDA approval for its lead ...

Key steps for pharmaceutical companies to meet FDA’s upcoming nitrosamine testing requirements and ensure product safety.

Akita Biosciences, Inc., a consumer health company that develops innovative nasal spray formulations for drug, device, and cosmetic applications, has received a grant from Flu Lab to evaluate the ...

Forms may also be drugs at some concentration in solid or liquid mixtures; 503A hospital and community pharmacies are more likely to use drug mixtures (e.g., commercial sterile IV additives and ...

Mainz Biomed announced that GANZIMMUN Diagnostics has officially launched the enhanced ColoAlert CRC screening test. Since ...

Somewhere in the body of a patient, a small clump of cells, growing undetected, has begun to form a tumor. It has yet to cause pain or visible symptoms of illness. Several months from now, or perhaps ...

Alibaba Group’s research arm, Damo Academy, has achieved a groundbreaking milestone in medical AI with its cancer detection ...